24/7 Market News Snapshot 16 September, 2025 – Silo Pharma, Inc. Common Stock (NASDAQ:SILO)

September 16, 2025

DENVER, Colo., 16 September, 2025 (www.247marketnews.com) – (NASDAQ:SILO) are discussed in this article.
Silo Pharma, Inc. (SILO) is currently experiencing a bullish trend in pre-market trading, with shares appreciating to $0.894, a notable increase of approximately 11.65% from the previous session’s close at $0.801. The robust trading volume of 6.05 million shares indicates a strong interest among investors, often seen as a precursor to further positive momentum. This price movement reflects increased market confidence in Silo Pharma’s forthcoming developments, warranting close attention from traders regarding resistance levels and overall market conditions to validate this optimism.

In a strategic move to enhance its asset portfolio, Silo has also embarked on a cryptocurrency treasury strategy. As announced on September 16, 2025, the company has initiated the acquisition of digital tokens, specifically Ethereum (ETH) and Solana (SOL). This diversification into cryptocurrency underscores Silo Pharma’s commitment to harnessing blockchain technology for long-term value creation, particularly in support of its biopharmaceutical initiatives. By integrating cryptocurrency into its financial arsenal, Silo aims not only to bolster its financial stability but also to explore innovative opportunities such as asset tokenization.

CEO Eric Weisblum has emphasized the company’s strategic outlook, stating, “Our initial purchases of Ethereum and Solana reflect our deep conviction in decentralized finance as leading smart contract platforms.” The company is also considering staking these tokens to generate additional revenue while advancing its clinical development programs aimed at addressing critical conditions such as PTSD, fibromyalgia, and various CNS diseases.

As Silo Pharma navigates this promising chapter, it remains focused on delivering groundbreaking therapeutic solutions and actively engages in research collaborations with prestigious universities and laboratories. Stakeholders can anticipate further announcements detailing progress in both its pharmaceutical and cryptocurrency ventures, reinforcing the company’s dual commitment to innovation and healthcare improvement.

Related news for (SILO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.